Finance

Lists
Why is AAREYDRUGS up 3,92%?
Dive Deeper
AAREYDRUGS:NSE
Aarey Drugs and Pharmaceuticals Ltd
113,00 ₹
+3,92%
(+4,26) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AAREYDRUGS...
Open
107,01 ₹
High
113,50 ₹
Low
105,21 ₹
Mkt. cap
3,61 մլրդ
Avg. vol.
227,25 հզր
Volume
187,21 հզր
P/E ratio
88,81
52-wk high
113,50 ₹
52-wk low
50,31 ₹
EPS
1,27 ₹
No. of employees
0
Open
107,01 ₹
High
113,50 ₹
Low
105,21 ₹
Mkt. cap
3,61 մլրդ
Avg. vol.
227,25 հզր
Volume
187,21 հզր
P/E ratio
88,81
52-wk high
113,50 ₹
52-wk low
50,31 ₹
EPS
1,27 ₹
No. of employees
0
News stories
From web sources and news partners
About Aarey Drugs and Pharmaceuticals Ltd
CEO-
Employees0
Founded1990
Headquarters-
Sector-
Websiteaareydrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
841,62 մլն
964,26 մլն
1,89 մլրդ
446,26 մլն
Cost of goods sold
804,83 մլն
967,96 մլն
1,79 մլրդ
421,54 մլն
Cost of revenue
804,83 մլն
967,96 մլն
1,79 մլրդ
421,54 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,08 մլն
4,25 մլն
-3,60 մլն
6,89 մլն
Operating expense
17,29 մլն
19,69 մլն
50,37 մլն
19,96 մլն
Total operating expenses
822,12 մլն
987,65 մլն
1,85 մլրդ
441,50 մլն
Operating income
19,50 մլն
-23,39 մլն
49,56 մլն
4,75 մլն
Other non operating income
7,93 մլն
41,82 մլն
-72,35 մլն
17,15 մլն
EBT including unusual items
14,82 մլն
9,24 մլն
12,80 մլն
5,16 մլն
EBT excluding unusual items
14,82 մլն
9,24 մլն
12,80 մլն
5,16 մլն
Income tax expense
4,58 մլն
3,54 մլն
2,77 մլն
-5,08 մլն
Effective tax rate
30,92%
38,35%
21,66%
-98,55%
Other operating expenses
4,29 մլն
7,18 մլն
45,51 մլն
4,57 մլն
Net income
10,24 մլն
5,70 մլն
10,03 մլն
10,24 մլն
Net profit margin
1,22%
0,59%
0,53%
2,29%
Earnings per share
-
-
-
-
Interest and investment income
-
-
46,30 մլն
-
Interest expense
-12,60 մլն
-9,19 մլն
-10,76 մլն
-16,74 մլն
Net interest expenses
-12,60 մլն
-9,19 մլն
35,54 մլն
-16,74 մլն
Depreciation and amortization charges
6,93 մլն
8,26 մլն
8,46 մլն
8,50 մլն
EBITDA
25,40 մլն
-18,53 մլն
56,69 մլն
11,88 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps